Switzerland Marina Lugova, executive VP Business Development at API manufacturer Synbias Pharma, discusses why Switzerland was chosen as the company’s headquarters, Synbias’s internationalization strategy, and why it is the partner of choice. We have chosen Switzerland for several reasons: a stable political and economic environment, the fact many Big Pharma…
See our Cookie Privacy Policy Here
